Abstract

Brain development requires the interaction of complex signaling pathways, involving different cell types and molecules. For a long time, most attention has focused on neurons in a neuronocentric conceptualization of central nervous system development, these cells fulfilling an intrinsic program that establishes the brain’s morphology and function. By contrast, glia have mainly been studied as support cells, offering guidance or as the cells that react to brain injury. However, new evidence is appearing that demonstrates a more fundamental role of glial cells in the control of different aspects of neuronal development and function, events in which the influence of neurons is at best weak. Moreover, it is becoming clear that the function and organization of the nervous system depends heavily on reciprocal neuron–glia interactions. During development, neurons are often generated far from their final destination and while intrinsic mechanisms are responsible for neuronal migration and growth, they need support and regulatory influences from glial cells in order to migrate correctly. Similarly, the axons emitted by neurons often have to reach faraway targets and in this sense, glia help define the way that axons grow. Moreover, oligodendrocytes and Schwann cells ultimately envelop axons, contributing to the generation of nodes of Ranvier. Finally, recent publications show that astrocytes contribute to the modulation of synaptic transmission. In this sense, purinergic receptors are expressed widely by glial cells and neurons, and recent evidence points to multiple roles of purines and purinergic receptors in neuronal development and function, from neurogenesis to axon growth and functional axonal maturation, as well as in pathological conditions in the brain. This review will focus on the role of glial and neuronal secreted purines, and on the purinergic receptors, fundamentally in the control of neuronal development and function, as well as in diseases of the nervous system.

Highlights

  • A plethora of different regulatory molecules are involved in the crosstalk between neurons and glia during neuronal development

  • PI3-kinase activity can be regulated through different membrane receptors and adhesion molecules, and recent studies identified a role for purines and purinergic receptors in the modulation of signaling pathways involved in axonal growth, such as that mediated by PI3-kinase

  • With regards purinergic signaling and amyotrophic lateral sclerosis (ALS), an up-regulation of P2X4, P2X7, and P2Y6 receptors has been observed in transgenic mice over-expressing human superoxide dismutase 1 (SOD1), an www.frontiersin.org animal model of ALS (D’Ambrosi et al, 2009), as well as the downregulation of ATP-hydrolyzing activities in microglia, suggesting that the pro-inflammatory actions of microglial P2 receptors are enhanced in this ALS model

Read more

Summary

Introduction

A plethora of different regulatory molecules are involved in the crosstalk between neurons and glia during neuronal development. EXPRESSION OF PURINES AND PURINERGIC RECEPTORS IN GLIAL CELLS AND NEURONS In the nervous system, ATP fulfils a relevant role in the regulation of several physiological functions involving neuron–glia signaling networks.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call